Dbv Technologies S.a. - Spons-adr Share Price Today
(NASDAQ: DBVT)

Name: Dbv Technologies S.a. - Spons-adr Share Price Today (NASDAQ: DBVT) - Dbv Technologies S.a. - Spons-adr Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Dbv Technologies S.a. - Spons-adr share price is $7.98 & ₹682.01 as on 18 Apr 2025, 2.30 'hrs' IST

$7.98

▲

0.07

(0.88%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Dbv Technologies S.a. - Spons-adr share price in Dollar and Rupees. Guide to invest in Dbv Technologies S.a. - Spons-adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Dbv Technologies S.a. - Spons-adr , along with analyst recommendations, forecasts, and comprehensive financials.

Dbv Technologies S.a. - Spons-adr share price movements

Today's Low: $7.66
Today's High: $8.41
$7.98
3.98%
Downside
Day's Volatility :8.89%
Upside
5.11%
52 Weeks Low: $2.20
52 Weeks High: $8.50
$7.98
72.37%
Downside
52 Weeks Volatility :74.06%
Upside
6.12%

Dbv Technologies S.a. - Spons-adr (DBVT) Returns

Period	Dbv Technologies S.a. - Spons-adr	Sector (Health Care)	Index (Russel 2000)
3 Months	76.55%	-2.8%	0.0%
6 Months	127.67%	-11.0%	0.0%
1 Year	17.06%	-1.9%	0.0%
3 Years	-43.4%	-1.5%	-12.9%

Dbv Technologies S.a. - Spons-adr (DBVT) Key Statistics

in dollars & INR

Previous Close	$7.91
Open	$7.91
Today's High	$8.41
Today's Low	$7.6627
Market Capitalization	$218.1M
Today's Volume	$58.0K
52 Week High	$8.5
52 Week Low	$2.2045
Revenue TTM	$4.2M
EBITDA	$-79.7M
Earnings Per Share (EPS)	$-5.85
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-135.96%

How to invest in Dbv Technologies S.a. - Spons-adr Stock (DBVT) from India?

It is very easy for Indian residents to invest directly in Dbv Technologies S.a. - Spons-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dbv Technologies S.a. - Spons-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dbv Technologies S.a. - Spons-adr or DBVT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dbv Technologies S.a. - Spons-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dbv Technologies S.a. - Spons-adr shares which would translate to 0.107 fractional shares of Dbv Technologies S.a. - Spons-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dbv Technologies S.a. - Spons-adr , in just a few clicks!

Returns in Dbv Technologies S.a. - Spons-adr (DBVT) for Indian investors in Rupees

The Dbv Technologies S.a. - Spons-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Dbv Technologies S.a. - Spons-adr investment value today

Current value as on today

₹1,19,350

Returns

₹19,350

(+19.35%)

Returns from Dbv Technologies S.a. - Spons-adr Stock

₹17,009 (+17.01%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Dbv Technologies S.a. - Spons-adr (DBVT)

78%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Dbv Technologies S.a. - Spons-adr Stock from India on INDmoney has increased by 78% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Dbv Technologies S.a. - Spons-adr

Baker Bros Advisors LP
7.12%
Yiheng Capital LLC
3.20%
Point72 Asset Management, L.P.
1.40%
UBS Group AG
0.79%
Boxer Capital LLC
0.24%
Boxer Capital Management, LLC
0.24%

Analyst Recommendation on Dbv Technologies S.a. - Spons-adr

Rating

Trend

Buy

75%Buy

12%Hold

12%Sell

Based on 8 Wall street analysts offering stock ratings for Dbv Technologies S.a. - Spons-adr (by analysts ranked 0 to 5 stars)

Analyst Forecast on Dbv Technologies S.a. - Spons-adr Stock (DBVT)

What analysts predicted

Upside of 196.44%

Target:

$23.66

Current:

$7.98

Insights on Dbv Technologies S.a. - Spons-adr Stock (Ticker Symbol: DBVT)

Price Movement
In the last 1 month, DBVT stock has moved up by 66.9%
Decreasing Revenue
Revenue is down for the last 3 quarters, 8.87M → 1.16M (in $), with an average decrease of 50.8% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -33.11M → -23.01M (in $), with an average increase of 20.5% per quarter
DBVT vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 60.1%
DBVT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 74.0%
Price to Sales
ForDBVT every $1 of sales, investors are willing to pay $37.1, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Dbv Technologies S.a. - Spons-adr Technicals Summary

Sell

Neutral

Buy

Dbv Technologies S.a. - Spons-adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Dbv Technologies S.a. - Spons-adr (DBVT) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Dbv Technologies S.a. - Spons-adr	49.81%	127.67%	17.06%	-43.4%	-82.95%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Dbv Technologies S.a. - Spons-adr	NA	NA	0.0	-0.94	-1.36	-0.59	NA	0.27
Regeneron Pharmaceuticals, Inc.	14.33	14.33	0.89	41.63	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.37	17.97	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Dbv Technologies S.a. - Spons-adr	Buy	$218.1M	-82.95%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.1B	-0.85%	14.33	31.07%
Beone Medicines Ltd	NA	$27.0B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.9B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$29.8B	61.91%	NA	-12.37%

About Dbv Technologies S.a. - Spons-adr

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. The company's product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. Its earlier stage research programs include vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

Organization	Dbv Technologies S.a. - Spons-adr
Employees	109
CEO	Mr. Daniel Tassé
Industry	Health Technology

Management People of Dbv Technologies S.a. - Spons-adr

Name	Title
Mr. Daniel Tassé	CEO & Director
Ms. Virginie Simone Jeanine Verrechia Boucinha M.B.A.	CFO & Principal Accounting Officer
Dr. Pharis Mohideen	Chief Medical Officer
Dr. Kevin P. Malobisky M.S., Ph.D., R.A.C.	Chief Operations Officer
Katie Matthews	Investor Relations Officer
Ms. Michele F. Robertson	Chief Legal Officer
Ms. Caroline Daniere	Chief Human Resources Officer & Chief of Staff
Dr. Wence Agbotounou	Chief Clinical Trial Officer & Senior VP
Mr. Edward P. Jordan M.B.A.	Senior Vice President of Commercial Operations North America
Alan Kerr	Senior VP & Head of Global Regulatory Affairs

Important FAQs about investing in DBVT Stock from India :

What is Dbv Technologies S.a. - Spons-adr share price today?

Dbv Technologies S.a. - Spons-adr share price today stands at $7.98, Open: $7.91 ; Previous Close: $7.91 ; High: $8.41 ; Low: $7.66 ; 52 Week High: $8.50 ; 52 Week Low: $2.20.

The stock opens at $7.91, after a previous close of $7.91. The stock reached a daily high of $8.41 and a low of $7.66, with a 52-week high of $8.50 and a 52-week low of $2.20.

Can Indians buy Dbv Technologies S.a. - Spons-adr shares?

Yes, Indians can invest in the Dbv Technologies S.a. - Spons-adr (DBVT) from India.

With INDmoney, you can buy Dbv Technologies S.a. - Spons-adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Dbv Technologies S.a. - Spons-adr at zero transaction cost.

How can I buy Dbv Technologies S.a. - Spons-adr shares from India?

It is very easy to buy Dbv Technologies S.a. - Spons-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dbv Technologies S.a. - Spons-adr (DBVT) be purchased?

Yes, you can buy fractional shares of Dbv Technologies S.a. - Spons-adr with INDmoney app.

What are the documents required to start investing in Dbv Technologies S.a. - Spons-adr stocks?

To start investing in Dbv Technologies S.a. - Spons-adr , You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.